Literature DB >> 23114600

Natriuretic peptides enhance the oxidative capacity of human skeletal muscle.

Stefan Engeli1, Andreas L Birkenfeld, Pierre-Marie Badin, Virginie Bourlier, Katie Louche, Nathalie Viguerie, Claire Thalamas, Emilie Montastier, Dominique Larrouy, Isabelle Harant, Isabelle de Glisezinski, Stefanie Lieske, Julia Reinke, Bibiana Beckmann, Dominique Langin, Jens Jordan, Cedric Moro.   

Abstract

Cardiac natriuretic peptides (NP) are major activators of human fat cell lipolysis and have recently been shown to control brown fat thermogenesis. Here, we investigated the physiological role of NP on the oxidative metabolism of human skeletal muscle. NP receptor type A (NPRA) gene expression was positively correlated to mRNA levels of PPARγ coactivator-1α (PGC1A) and several oxidative phosphorylation (OXPHOS) genes in human skeletal muscle. Further, the expression of NPRA, PGC1A, and OXPHOS genes was coordinately upregulated in response to aerobic exercise training in human skeletal muscle. In human myotubes, NP induced PGC-1α and mitochondrial OXPHOS gene expression in a cyclic GMP-dependent manner. NP treatment increased OXPHOS protein expression, fat oxidation, and maximal respiration independent of substantial changes in mitochondrial proliferation and mass. Treatment of myotubes with NP recapitulated the effect of exercise training on muscle fat oxidative capacity in vivo. Collectively, these data show that activation of NP signaling in human skeletal muscle enhances mitochondrial oxidative metabolism and fat oxidation. We propose that NP could contribute to exercise training-induced improvement in skeletal muscle fat oxidative capacity in humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23114600      PMCID: PMC3533552          DOI: 10.1172/JCI64526

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

Review 1.  Percutaneous needle biopsy of skeletal muscle in physiological and clinical research.

Authors:  J Bergstrom
Journal:  Scand J Clin Lab Invest       Date:  1975-11       Impact factor: 1.713

2.  Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice.

Authors:  Julio E Ayala; Deanna P Bracy; Brianna M Julien; Jeffrey N Rottman; Patrick T Fueger; David H Wasserman
Journal:  Diabetes       Date:  2007-01-17       Impact factor: 9.461

3.  Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity.

Authors:  Elizabeth V Menshikova; Vladimir B Ritov; Frederico G S Toledo; Robert E Ferrell; Bret H Goodpaster; David E Kelley
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-12-07       Impact factor: 4.310

4.  Changes in resting metabolic rate and substrate oxidation after 16 months of exercise training in overweight adults.

Authors:  Jeffrey A Potteiger; Erik P Kirk; Dennis J Jacobsen; Joseph E Donnelly
Journal:  Int J Sport Nutr Exerc Metab       Date:  2008-02       Impact factor: 4.599

5.  Impact of obesity on plasma natriuretic peptide levels.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2004-02-10       Impact factor: 29.690

Review 6.  Control of lipolysis by natriuretic peptides and cyclic GMP.

Authors:  Max Lafontan; Cédric Moro; Michel Berlan; François Crampes; Coralie Sengenes; Jean Galitzky
Journal:  Trends Endocrinol Metab       Date:  2008-03-11       Impact factor: 12.015

Review 7.  PGC-1 coactivators: inducible regulators of energy metabolism in health and disease.

Authors:  Brian N Finck; Daniel P Kelly
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

8.  The effect of exercise-training on resting metabolic rate in lean and moderately obese individuals.

Authors:  A Tremblay; E Fontaine; E T Poehlman; D Mitchell; L Perron; C Bouchard
Journal:  Int J Obes       Date:  1986

9.  Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity.

Authors:  Riccardo Sarzani; Pasquale Strazzullo; Fabio Salvi; Roberto Iacone; Francesca Pietrucci; Alfonso Siani; Gianvincenzo Barba; Maria Clara Gerardi; Paolo Dessì-Fulgheri; Alessandro Rappelli
Journal:  Obes Res       Date:  2004-02

10.  Atrial natriuretic peptide induces postprandial lipid oxidation in humans.

Authors:  Andreas L Birkenfeld; Petra Budziarek; Michael Boschmann; Cedric Moro; Frauke Adams; Gabriele Franke; Michel Berlan; Marie A Marques; Fred C G J Sweep; Friedrich C Luft; Max Lafontan; Jens Jordan
Journal:  Diabetes       Date:  2008-10-03       Impact factor: 9.461

View more
  69 in total

Review 1.  A heart-adipose tissue connection in the regulation of energy metabolism.

Authors:  Sheila Collins
Journal:  Nat Rev Endocrinol       Date:  2013-12-03       Impact factor: 43.330

Review 2.  Corin in natriuretic peptide processing and hypertension.

Authors:  Yiqing Zhou; Qingyu Wu
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

3.  [Pathophysiology of hypertension : What are our current concepts?].

Authors:  J Jordan
Journal:  Internist (Berl)       Date:  2015-03       Impact factor: 0.743

Review 4.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

5.  Metabolic effects of sacubitril/valsartan: are they relevant in clinical practice?

Authors:  Rafael de la Espriella-Juan; Juan Sanchis; Antoni Bayés-Genís; Julio Núñez
Journal:  Cardiovasc Diagn Ther       Date:  2018-08

6.  Sex-specific association between soluble corin and metabolic syndrome in Chinese adults.

Authors:  Hongmei Li; Qiu Zhang; Yan He; Jijun Shi; Weidong Hu; Hao Peng
Journal:  Hypertens Res       Date:  2019-02-14       Impact factor: 3.872

7.  Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy.

Authors:  Michael M Kreusser; Lorenz H Lehmann; Stanislav Keranov; Marc-Oscar Hoting; Ulrike Oehl; Michael Kohlhaas; Jan-Christian Reil; Kay Neumann; Michael D Schneider; Joseph A Hill; Dobromir Dobrev; Christoph Maack; Lars S Maier; Hermann-Josef Gröne; Hugo A Katus; Eric N Olson; Johannes Backs
Journal:  Circulation       Date:  2014-08-14       Impact factor: 29.690

Review 8.  Natriuretic peptides in cardiometabolic regulation and disease.

Authors:  Nora E Zois; Emil D Bartels; Ingrid Hunter; Birgitte S Kousholt; Lisbeth H Olsen; Jens P Goetze
Journal:  Nat Rev Cardiol       Date:  2014-05-13       Impact factor: 32.419

Review 9.  Coordinate control of adipose 'browning' and energy expenditure by β-adrenergic and natriuretic peptide signalling.

Authors:  S Collins; R Sarzani; M Bordicchia
Journal:  Int J Obes Suppl       Date:  2014-07-08

10.  Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: The cardiovascular health study.

Authors:  Erika F Brutsaert; Mary L Biggs; Joseph A Delaney; Luc Djoussé; John S Gottdiener; Joachim H Ix; Francis Kim; Kenneth J Mukamal; David S Siscovick; Russell P Tracy; Ian H de Boer; Christopher R deFilippi; Jorge R Kizer
Journal:  Metabolism       Date:  2016-06-24       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.